Lifestyle and demographic factors in relation to vasomotor symptoms: Baseline results from the study of women's health across the nation

American Journal of Epidemiology

Volumn 159, Issue 12, 2004, Pages 1189-1199

  Gold, Ellen B ^a   Block, Gladys ^b   Crawford, Sybil ^c   Lachance, Laurie ^d   FitzGerald, Gordon ^c   Miracle, Heidi ^e   Sherman, Sheryl ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e University of Massachusetts ^*

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Diet; Ethnic groups; Menopause; Reproductive history; Signs and symptoms; Smoking; Tobacco smoke pollution

Indexed keywords

ALCOHOL; ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ESTRADIOL; GENISTEIN; PHYTOESTROGEN; RETINOL;

WOMENS HEALTH;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CHINESE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; ETHNIC GROUP; FEMALE; GONADOTROPIN RELEASE; HORMONAL THERAPY; HORMONE RELEASE; HUMAN; JAPAN; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; NUCLEOTIDE SEQUENCE; RISK ASSESSMENT; SELF REPORT; SMOKING; SPAIN; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VASOMOTOR DISORDER;

EID: 2942550597     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh168     Document Type: Article

References (116)

1. McKinlay SM, Jeffreys M. The menopausal syndrome. Br J Prev Soc Med 1974;28:108-15.
2. Thompson B, Hart SA, Durno D. Menopausal age and symptomatology in a general practice. J Biosoc Sci 1973;5:71-82.
3. Schwingl PJ, Hulka BS, Harlow SD. Risk factors for menopausal hot flashes. Obstet Gynecol 1994;84:29-34.
4. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-73.
5. Gold EB. Demographics, environmental influences, and ethnic and international differences in the menopausal experience. In: Lobos R, Marcus R, Kelsey JL, eds. Menopause. New York, NY: Academic Press, 2000.
6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
7. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13.
8. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:49-57.
9. Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002;288:58-66.
10. Huang MH, Harrison GG, Mohamed MM, et al. Assessing the accuracy of a food frequency questionnaire for estimating usual intake of phytoestrogens. Nutr Cancer 2000;37:145-54.
11. Boulet MJ, Oddens BJ, Lehert P, et al. Climacteric and menopause in seven southeast Asian countries. Maturitas 1994;19:157-76.
12. Haines CJ, Chung TKH, Leung DHY. A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women. Maturitas 1994;18:175-81.
13. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988;10:317-32.
14. Samsioe G, Bryman I, Ivarsson E. Some anthropological aspects of the climacteric syndrome. Acta Obstet Gynecol Scand Suppl 1985;130:5-7.
15. Randolph JF Jr, Sowers MF, Gold EB, et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003;88:1516-22.
16. Wang DY, Key TJA, Pike MC, et al. Serum hormone levels in British and rural Chinese females. Breast Cancer Res Treat 1991;18(suppl 1):S41-5.
17. Key TJA, Chen J, Wang DY, et al. Sex hormones in women in rural China and in Britain. Br J Cancer 1990;62:631-6.
18. Shimizu H, Ross RK, Bernstein L, et al. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer 1990;62:451-3.
19. Shutt DA, Cox RI. Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J Endocrinol 1972;52:299-310.
20. Martin PM, Horwitz KB, Ryan DS, et al. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978;103:1860-7.
21. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;129:758-67.
22. Cassidy A, Bingham S, Carlson J, et al. Biological effects of plant estrogens in premenopausal women. (Abstract). FASEB J 1993;7:A866.
23. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:33-40.
24. Adlercreutz H, Fotsis T, Bannwart C, et al. Determination of urinary lignans and phytoestrogen metabolites, potential anti-estrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986;25:791-7.
25. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68(suppl):1333S-46S.
26. Adlercreutz H, Hockerstedt K, Bannwart C. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987;27:1135-44.
27. Barton D, Loprinzi CL, Quella SK, et al. Prospective evaluations of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol 1998;16:495-500.
28. Jensen J, Christiansen C, Rodbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med 1985;313:973-5.
29. MacMahon B, Trichopoulos D, Cole P, et al. Cigarette smoking and urinary estrogens. N Engl J Med 1982;307:1062-5.
30. Kuh DL, Wadsworth M, Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynecol 1997;104:923-33.
31. Leidy LE. Menopausal symptoms and everyday complaints. Menopause 1997;4:154-60.
32. Collins A, Landgren B-M. Reproductive health, use of estrogen and experience of symptoms in peri-menopausal women, a population-based study. Maturitas 1995;20:101-11.
33. Dennerstein L, Smith AMA, Morse CA. Menopausal symptomatology: the experience of Australian women. Med J Aust 1993;159:232-6.
34. Hunter MS. Predictors of menopausal symptoms: psychosocial aspects. Baillieres Clin Endocrinol Metab 1993;7:33-45.
35. Whiteman MK, Starpoli CA, Benedict JC, et al. Risk factors for hot flashes in midlife women. J Womens Health (Larchmt) 2003;12:459-72.
36. Sowers MF, Crawford S, Sternfeld B, et al. Design, survey sampling and recruitment methods of SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition. In: Lobos R, Marcus R, Kelsey JL, eds. Menopause. New York, NY: Academic Press, 2000:175-88.
37. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
38. Subar AF, Thompson FE, Kipnis V, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Am J Epidemiol 2001;154:1089-99.
39. Block G, Thompson F, Hartman AM, et al. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992;92:686-93.
40. Reinli K, Block G. Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 1996;26:123-48.
41. Block G, Norris JC, Mandel RM, et al. Sources of energy and six nutrients in diets of low-income Hispanic-American women and their children: quantitative data from the HHANES, 1982-1984. J Am Diet Assoc 1995;95:195-208.
42. Matthews KA, Wing RR, Kuller LH, et al. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 1994;154:2349-55.
43. Neurgarten BL, Kraines RJ. Menopausal symptoms in women of various ages. Psychosom Med 1965;27:266-73.
44. Avis NE, McKinlay SM. A longitudinal analysis of women's attitudes toward the menopause: results from the Massachusetts Women's Health Study. Maturitas 1991;13:65-79.
45. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
46. Coghlin J, Hammond SK, Gann PH. Development of epidemiologic tools for measuring environmental tobacco smoke exposure. Am J Epidemiol 1989;130:696-704.
47. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705-14.
48. Sheldon C, Williamson G. Perceived stress in a probability sample of the United States. In: Spacan S, Oskam S, eds. The social psychology of health. Newbury Park, CA: Sage, 1988:31-67.
49. Marin G, Sabogal F, Marin BV, et al. Development of a short acculturation scale for Hispanics. Hispanic J Behav Sci 1987;9:183-205.
50. Sternfeld B, Ainsworth BA, Quesenberry CP Jr. Physical activity patterns in a diverse population of women. Prev Med 1999;28:313-23.
51. Baecke JAH, Burema J, Fritjers JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-42.
52. Agresi A. The analysis of ordinal categorical data. New York, NY: John Wiley, 1984.
53. Hosmer DW, Lemeshow S. Applied logistic regression. New York, NY: John Wiley, 1989.
54. Bender R, Grouven U. Using binary logistic regression models for ordinal data with non-proportional odds. J Clin Epidemiol 1998;51:809-16.
55. Akaike H. Likelihood of a model and information criteria. J Econometrics 1981;16:3-14.
56. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at menopause in a multiethnic population of women. Am J Epidemiol 2001;153:865-74.
57. Glickman-Weiss EL, Nelson AG, Hearon CM, et al. Thermal and metabolic responses of women with high fat versus low fat body composition during exposure to 5 and 27 degrees C for 120 min. Aviat Space Environ Med 1999;70:284-8.
58. Tikuisis P, Jacobs I, Moroz D, et al. Comparison of thermoregulatory responses between men and women immersed in cold water. J Appl Physiol 2000;89:1403-11.
59. Zumoff B, Strain GW, Kream J, et al. Obese young men have elevated plasma estrogen levels but obese premenopausal women do not. Metabolism 1981;30:1011-14.
60. Hahn PM, Wong J, Reid RL. Menopausal-like hot flashes reported in women of reproductive age. Fertil Steril 1998;70:913-18.
61. Skarsgard C, Bjors E, Nedstrand E, et al. Do women's premenstrual symptoms and their mother's climacteric history predispose to their own vasomotor symptoms? Menopause 1996;3:133-9.
62. Hart P, Farrell GC, Cooksley WG, et al. Enhanced drug metabolism in cigarette smokers. Br Med J 1976;2:147-9.
63. Lindquist O, Bengtsson C. Menopausal age in relation to smoking. Acta Med Scand 1979;205:73-7.
64. Michnovicz J, Hershcopf R, Naganuma H, et al. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med 1986;315:1305-9.
65. Casper RF, Yen SS, Wilkes MM. Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion. Science 1979;205:823-5.
66. Hutton JD, Jacobs HS, Murray MAF, et al. Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1978;1:671-81.
67. Askel S, Schomberg DW, Tyrey L, et al. Vasomotor symptoms, serum estrogens, and gonadotropin levels in surgical menopause. Am J Obstet Gynecol 1976;126:165-9.
68. Stone SC, Mickal A, Rye F, et al. Postmenopausal symptomatology, maturation index, and plasma estrogen levels. Obstet Gynecol 1975;45:625-7.
69. Freedman RR, Norton D, Woodward S, et al. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354-8.
70. Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;65:1141-4.
71. Starpoli CA, Flaws JA, Bush TL, et al. Predictors of menopausal hot flashes. J Womens Health 1998;7:1149-55.
72. Leidy L. Comparison of body size and age of menopause between Mexican-American and white American women. Ann N Y Acad Sci 1990;592:443-4.
73. Bennetts HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust Vet J 1946;22:2-12.
74. Vincent A, Fitzpatrick LA. Soy isoflavones: are they useful in menopause? Mayo Clin Proc 2000;75:1174-84.
75. Zava DT, Duwe G. Estrogenic and antiproliferative properties and other flavonoids in human breast cancer cells in vivo. Nutr Cancer 1997;27:31-40.
76. Adlercreutz H, Mazur W. Phtyo-oestrogens and western diseases. Ann Med 1997;29:95-120.
77. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-904.
78. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-35.
79. Lu LH, Anderson KE, Grady JJ, et al. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 1996;5:63-70.
80. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 1995;74:587-601.
81. Loukovaara M, Carson M, Palotie A, et al. Regulation of sex hormone binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 1995;60:656-61.
82. Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of sex hormone binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993;58:301-4.
83. Adlercreutz H, Hockerstedt K, Bannwart C, et al. Effect of dietary components, including lignans and phytoestrogens on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987;27:1135-44.
84. Wu AH, Stanczyk FZ, Hendrich S, et al. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 2000;82:1879-86.
85. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995;80:1685-90.
86. Shultz TD, Bonorden WR, Seaman WR. Effect of short-term flaxseed consumption on lignan and sex hormone metabolism in men. Nutr Res 1991;11:1089-100.
87. Phipps WR, Martini MC, Lampe JW, et al. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab 1993;77:1215-19.
88. Murkies AL, Lombard C, Strauss BJG. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas 1985;21:189-95.
89. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
90. Harding C, Morton M, Gould V, et al. Dietary soy supplementation is oestrogenic in menopausal women. Presented at the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Brussels, Belgium, September 13-18, 1996.
91. Washburn S, Burke GL, Morgan T, et al. Effect of soy protein supplementation on serum lipoproteins, blood pressure and menopausal symptoms in perimenopausal women. Menopause 1999;6:7-13.
92. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7:105-11.
93. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997;4:89-94.
94. Upmalis DH, Lobo R, Bradley L, et al. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized placebo controlled study. Menopause 2000;7:236-42.
95. Faure ED, Chantre P, Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized placebo-controlled study. Menopause 2002;9:329-34.
96. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group trial. J Clin Oncol 2000;18:1068-74.
97. St Germain A, Peterson CT, Robinson JG, et al. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001;8:17-26.
98. Woods MN, Senie R, Kronenberg F. Effect of a dietary soy bar on menopausal symptoms. Presented at the Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Brussels, Belgium, September 13-18, 1996.
99. Burke GL, Legault C, Anthony M, et al. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 2003;10:147-53.
100. Nagata C, Shimizu H, Takami R, et al. Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women. Climacteric 1999;2:6-12.
101. Elkind-Hirsch K. Effect of dietary phytoesetrogens on hot flushes: can soy-based proteins substitute for traditional estrogen replacement therapy? (Editorial). Menopause 2001;8:154-6.
102. Adlercreutz H. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest 1990;210:3-23.
103. Rose DP, Boyar AP, Cohen C, et al. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. J Natl Cancer Inst 1987;78:623-6.
104. Boyar AP, Rose DP, Loughridge JR, et al. Response to a diet low in total fat in women with postmenopausal breast cancer: a pilot study. Nutr Cancer 1988;11:93-9.
105. Prentice R, Thompson D, Clifford C, et al. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. J Natl Cancer Inst 1990;82:129-34.
106. Rose DP, Goldman M, Connolly JM, et al. High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr 1991;54:520-5.
107. Shultz TD, Howie BJ. In vitro binding of steroid hormones by natural and purified fibers. Nutr Cancer 1986;8:141-7.
108. Whitten CG, Shultz TD. Binding of steroid hormone in vitro by water-soluble dietary fiber. (Abstract). FASEB J 1988;1:A862.
109. Goldin BR, Adlercreutz MD, Gorbach MD, et al. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women. Am J Clin Nutr 1986;44:945-53.
110. Markides CS, Roy D, Liehr JG. Concentration dependence of pro-oxidant and antioxidant properties of catecholestrogens. Arch Biochem Biophys 1998;360:105-12.
111. Liehr JG. Antioxidant and pro-oxidant properties of estrogens: potential physiological and clinical implications. Lab Clin Med 1996;128:344-5.
112. Nathan L, Chaudhuri G. Antioxidant and pro-oxidant actions of estrogens: potential physiological and clinical implications. Semin Reprod Endocrinol 1998;16:309-14.
113. Krstevska M, Dzhekova-Stojkova S, Bosilkova G. Menopause, coronary artery disease and antioxidants. Clin Chem Lab Med 2001;39:641-4.
114. Rifici VA, Khachadurian AK. The inhibition of low density lipoprotein oxidation by 17β-estradiol. Metabolism 1992;40:1110-14.
115. Ayres S, Tang M, Subbiah MT. Estradiol-17β as an antioxidant: some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med 1996;128:367-75.
116. Thibodeau PA, Kachadourian R, Lemay R, et al. In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol 2002;81:227-36.